Papers
44
Total Citations
2,557
H-Index
21
About
Lee Richstone is a prominent urologic surgeon and researcher whose work has fundamentally shaped the evolution of minimally invasive and robotic surgery, with a particular focus on bladder cancer treatment and advanced laparoscopic techniques. He is best known for his leadership within the International Robotic Cystectomy Consortium (IRCC), a collaborative research body that has produced landmark multi-institutional data on robot-assisted radical cystectomy (RARC). His contributions have helped define the learning curve, complication profiles, oncologic outcomes, and surgical margin standards for RARC, with individual studies accumulating between 89 and 307 citations — reflecting their lasting influence on clinical practice worldwide. Beyond cystectomy, Richstone has made significant contributions to emerging surgical frontiers, including laparoendoscopic single-site surgery (LESS) and natural orifice transluminal endoscopic surgery (NOTES), authoring comprehensive analyses that earned over 250 citations each. His early investigation into FDA-reported robotic device failures demonstrated a commitment to surgical safety and transparency. Collectively, his body of work bridges technical innovation with rigorous outcomes research, providing the evidence base that has guided urologists in adopting and refining robotic approaches to complex pelvic surgery. His scholarship remains essential reading for surgeons and trainees navigating the rapidly advancing landscape of robotic urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10